Anavex Life Sciences (AVXL) Non Operating Income (2016 - 2026)
Anavex Life Sciences' Non Operating Income came in at $1.09 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 10.6% from $1.22 million a year earlier and down 5.1% from the prior quarter.
Anavex Life Sciences (AVXL) Non Operating Income (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Anavex Life Sciences reported Non Operating Income of $4.37 million, down 34.4% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $5.03 million, down 49.1% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Going back by fiscal year, Non Operating Income was $9.88 million in FY2024 (+19.6%), $8.26 million in FY2023 (+145.3%), $3.37 million in FY2022 (-22.8%) and $4.36 million in FY2021 (-9.7%).
- The five-year range for quarterly Non Operating Income is $179,800 (fiscal Q3 2022) to $2.76 million (fiscal Q1 2024).
- Year-over-year, Non Operating Income has declined for seven consecutive quarters, with an average decline of 29.1% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in fiscal Q1 2023 (growth of 174.6%), and the weakest in fiscal Q3 2022 (a decline of 85.7%).
- Business Quant data shows AVXL's Non Operating Income at $1.15 million (Q2 2026), $1.12 million (Q1 2026) and $1.02 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Anavex Life Sciences | 175.20 Mn | -304.88 Mn | - | 1.09 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.76 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 2.39 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 179,800.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 871,003.00 |
| Sep 30, 2021 | 676,743.00 |
Anavex Life Sciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();